Physician profile
David B Silverman
NPI 1487738407
$652.46
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2021: $122 · 2022: $44.51 · 2023: $170 · 2024: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $147.81 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $140.10 | 2019-2021 | |
| Ethicon US, LLC | $67.48 | 2024 | Surgicel Nu-Knit, Stratafix |
| Mayne Pharma Commercial LLC | $44.57 | 2022-2023 | |
| Coopersurgical, INC. | $42.74 | 2023-2024 | Paragard T 380a, Wallach Cryosurgical Equipment |
| Merck Sharp & Dohme LLC | $39.23 | 2019-2024 | Gardasil, Gardasil 9 |
| Abbvie INC. | $37.69 | 2019-2024 | |
| Organon LLC | $29.64 | 2024 | |
| Sumitomo Pharma America, INC. | $23.64 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $22.70 | 2019 | |
| Pfizer INC. | $22.44 | 2023 | |
| Millicent US INC | $19.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Silverman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.